Skip to main content

Cholecystitis

4
Pipeline Programs
5
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
2 programs
1
Deep to Moderate NMBPhase 4
Cholecystectomy visualizationN/A
MSD
MSDIreland - Ballydine
2 programs
1
Deep to Moderate NMBPhase 41 trial
Cholecystectomy visualizationN/A1 trial
Active Trials
NCT02264444Completed30Est. Aug 2016
NCT02812186Completed79Est. Feb 2019
JSC Valenta Pharmaceuticals
2 programs
2
4-MUST, 1 tabletPhase 11 trial
4-MUST, 2 tablets, fastedPhase 11 trial
Active Trials
NCT06315387Unknown42Est. Dec 2024
NCT06342804Unknown24Est. Dec 2024
Stryker
StrykerCA - San Jose
1 program
Injection of indocyanine greenN/A1 trial
Active Trials
NCT02070640Completed99Est. Aug 2014
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
NOTES assisted laparoscopic cholecystectomyN/A1 trial
Active Trials
NCT01174069Completed25Est. Oct 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
MSDDeep to Moderate NMB
JSC Valenta Pharmaceuticals4-MUST, 2 tablets, fasted
JSC Valenta Pharmaceuticals4-MUST, 1 tablet
MSDCholecystectomy visualization
StrykerInjection of indocyanine green
Oregon TherapeuticsNOTES assisted laparoscopic cholecystectomy

Clinical Trials (6)

Total enrollment: 299 patients across 6 trials

NCT02812186MSDDeep to Moderate NMB

Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery

Start: Dec 2016Est. completion: Feb 201979 patients
Phase 4Completed
NCT06342804JSC Valenta Pharmaceuticals4-MUST, 2 tablets, fasted

Food Effect on the Bioavailability of 4-MUST, Tablets, 128 mg

Start: Mar 2024Est. completion: Dec 202424 patients
Phase 1Unknown
NCT06315387JSC Valenta Pharmaceuticals4-MUST, 1 tablet

Safety, Tolerability and Pharmacokinetics of 4-MUST, Tablets, 128 mg (Valenta Pharm JSC) During Single and Multiple Oral Administration in Healthy Volunteers

Start: Dec 2023Est. completion: Dec 202442 patients
Phase 1Unknown
NCT02264444MSDCholecystectomy visualization

Establishing Visualization Grading Scale on LESS Cholecystectomy

Start: Sep 2013Est. completion: Aug 201630 patients
N/ACompleted
NCT02070640StrykerInjection of indocyanine green

Near Infrared Fluorescence Cholangiography (NIRF-C) During Cholecystectomy

Start: Jan 2013Est. completion: Aug 201499 patients
N/ACompleted
NCT01174069Oregon TherapeuticsNOTES assisted laparoscopic cholecystectomy

Natural Orifice Transgastric Endoscopic Surgical Removal of the Gallbladder

Start: May 2007Est. completion: Oct 201525 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.